Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
Most Doc Groups Unhappy With Proposed Congressional Budget Deal
A deal agreed to by congressional negotiators over the weekend would increase Medicare physician pay by 1.68%, but doctors’ groups expressed concern that it wouldn’t